Guaifenesin
Pricing Report NDC 51660-070-21

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The current wholesale acquisition cost for Guaifenesin (NDC 51660-070-21) is $0.29510 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 18, 2026.

As a provided by Ohm Laboratories Inc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.29510
Per EA

Effective Date
Feb 18, 2026
Billable Units
1 EA
Estimated Package Price
$0.30
Data Status
As of Feb 18, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2024, the NADAC wholesale price for (NDC ) has moved within a range of $0.29394 to $0.39928 per EA. Over this 1 year and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2939 - $0.3993
Market Volatility
35.84% Variance
Latest Trend
0.39%
Date Unit Price Unit Source Method Rate
Feb 18, 2026 $0.29510 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $0.29394 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $0.30285 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $0.30912 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $0.32115 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $0.31928 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $0.33413 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $0.33102 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $0.32861 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $0.32330 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $0.31983 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $0.33120 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $0.32454 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $0.35297 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $0.34521 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $0.39928 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $0.32011 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $0.35791 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2024 $0.30672 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 24, 2024 $0.34840 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: June 17, 2026